Tag: PW

Viral Safety in Biologics: Inactivation, Removal and Validation Viral Safety in Biologics: Ensuring Inactivation, Removal, and Validation Ensuring viral safety in biologics is a paramount concern for pharmaceutical manufacturers operating under stringent regulatory frameworks in the US, UK, and EU. Robust strategies focusing on sterility assurance, pharma microbiology, and validated water systems are essential to…

Read More “Viral Safety in Biologics: Inactivation, Removal and Validation” »

Microbiology and PAT: Real-Time Monitoring Technologies and Their Limits Microbiology and PAT: Advances and Constraints in Real-Time Monitoring Technologies In pharmaceutical manufacturing, sterility assurance and stringent control over microbial contamination represent critical quality attributes. The integration of Process Analytical Technology (PAT) into pharma microbiology workflows has accelerated the move toward real-time monitoring, offering significant advantages…

Read More “Microbiology and PAT: Real-Time Monitoring Technologies and Their Limits” »

Using Simulation Studies to Validate Microbial Control in Complex Lines Simulation Studies for Validation of Microbial Control in Complex Pharmaceutical Utility Lines Ensuring sterility assurance and microbial control is a fundamental requirement in pharmaceutical manufacturing, particularly when dealing with complex lines involving Purified Water (PW), Water for Injection (WFI), clean steam, and other critical GMP…

Read More “Using Simulation Studies to Validate Microbial Control in Complex Lines” »

Implementation of ATP and Fluorescence-Based Environmental Monitoring Step-by-Step Guide to Implementing ATP and Fluorescence-Based Environmental Monitoring in Pharmaceutical Manufacturing Ensuring sterility assurance remains a cornerstone of pharmaceutical manufacturing and quality control, particularly in sterile product environments. The integration of advanced technologies such as Adenosine Triphosphate (ATP) and fluorescence-based environmental monitoring techniques into pharma microbiology programs…

Read More “Implementation of ATP and Fluorescence-Based Environmental Monitoring” »

Viable but Non-Culturable (VBNC) Microorganisms: Relevance for Pharma Understanding Viable but Non-Culturable (VBNC) Microorganisms: Essential Guidance for Pharma Sterility Assurance Pharmaceutical bioprocesses and sterile manufacturing operations increasingly acknowledge the risks posed by viable but non-culturable (VBNC) microorganisms. These microbes challenge conventional microbiological methods, as they remain metabolically active yet resist growth on standard culture media….

Read More “Viable but Non-Culturable (VBNC) Microorganisms: Relevance for Pharma” »

Microbiological Risk Assessment for New Facilities and Processes Step-by-Step Guide: Microbiological Risk Assessment for New Pharma Facilities and Processes Establishing a new pharmaceutical manufacturing facility or introducing new processes demands rigorous microbiological risk assessment to ensure robust sterility assurance and compliance with global Good Manufacturing Practice (GMP) requirements. With complex interactions among pharma microbiology factors,…

Read More “Microbiological Risk Assessment for New Facilities and Processes” »

Managing Seasonal Microbiological Variability in Water and EM Programs Effective Management of Seasonal Microbiological Variability in Water and Environmental Monitoring Programs Pharmaceutical manufacturers face a critical challenge in maintaining consistent sterility assurance throughout the year due to seasonal microbiological variability affecting water systems and environmental monitoring (EM) programs. This tutorial provides a comprehensive, step-by-step guide…

Read More “Managing Seasonal Microbiological Variability in Water and EM Programs” »

Handling Positive Sterility and EM Results in ATMP and Cell Therapy Facilities Step-by-Step Guide to Handling Positive Sterility and Environmental Monitoring Results in ATMP and Cell Therapy Facilities Advanced Therapy Medicinal Products (ATMP) and cell therapy manufacturing require the highest standards of sterility assurance due to the direct patient administration of these products. The complex…

Read More “Handling Positive Sterility and EM Results in ATMP and Cell Therapy Facilities” »

Microbial Identification: When To Go to Genus, Species and Strain Level Microbial Identification: When To Go to Genus, Species and Strain Level In pharmaceutical manufacturing, particularly under stringent GMP utilities programs, understanding the microbial profile within production and sterile environments is essential. Robust sterility assurance depends on a comprehensive microbial monitoring paradigm that extends beyond…

Read More “Microbial Identification: When To Go to Genus, Species and Strain Level” »

Use of MALDI-TOF and Rapid ID Systems in GMP Microbiology Implementing MALDI-TOF and Rapid Identification Systems in GMP Microbiology for Sterility Assurance Pharmaceutical microbiology is a cornerstone of sterility assurance and product quality within Good Manufacturing Practice (GMP) regulated environments. Modern microbiological identification techniques like Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) mass spectrometry and…

Read More “Use of MALDI-TOF and Rapid ID Systems in GMP Microbiology” »